Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IKC and TACE in Hepatocellular Carcinoma
NCT03592706Phase 3Unknown
- Sponsor
- Ivy Life Sciences
- Start
- Dec 2009
- Primary completion
- Feb 2021
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 3 trial of IKC in hepatocellular carcinoma (HCC), sponsored by Ivy Life Sciences. Status: unknown.
02
Drugs
IKC
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03592706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03592706.